273 related articles for article (PubMed ID: 4729319)
1. Cyclophosphamide (NSC-26271) as adjuvant to radiotherapy in the treatment of unresectable bronchogenic carcinoma.
Host H
Cancer Chemother Rep 3; 1973 Mar; 4(2):161-4. PubMed ID: 4729319
[No Abstract] [Full Text] [Related]
2. Radiotherapy for bronchogenic carcinoma: actual difficulties and plans for the future.
Dana M
Cancer Chemother Rep 3; 1973 Mar; 4(2):153-5. PubMed ID: 4734076
[No Abstract] [Full Text] [Related]
3. Alternative approaches to radiotherapy alone and radiotherapy as a part of a combined therapeutic approach for lung cancer.
Holsti LR
Cancer Chemother Rep 3; 1973 Mar; 4(2):165-9. PubMed ID: 4125739
[No Abstract] [Full Text] [Related]
4. Effects of long-term adjuvant chemotherapy with cyclophosphamide (NSC-26271) for radically resected bronchogenic carcinoma.
Brunner KW; Marthaler T; Müller W
Cancer Chemother Rep 3; 1973 Mar; 4(2):125-32. PubMed ID: 4199643
[No Abstract] [Full Text] [Related]
5. A clinical trial of cyclophosphamide (NSC-26271) and radiation therapy for oat cell carcinoma of the lung.
Tucker RD; Sealy R; van Wyk C; le Roux PL; Soskolne CL
Cancer Chemother Rep 3; 1973 Mar; 4(2):159-60. PubMed ID: 4354040
[No Abstract] [Full Text] [Related]
6. Chemotherapy as an adjunct to surgery in the treatment of pulmonary malignant disease.
Mountain CF
Acta Chir Belg; 1971 Apr; 70(4):351-64. PubMed ID: 5143081
[No Abstract] [Full Text] [Related]
7. Radiation therapy for cancer of the lung: previous experience and definition of current issues.
Perez CA
Cancer Chemother Rep 3; 1973 Mar; 4(2):145-52. PubMed ID: 4354039
[No Abstract] [Full Text] [Related]
8. [VP 16-213 in combination with endoxan, methotrexate and oncovin as polychemotherapy for bronchogenic carcinoma].
Ryssel HJ; Hasler E; Sonntag RW; Cavalli F; Martin J; Tschopp L; Brunner KW
Schweiz Med Wochenschr; 1977 Jul; 107(26):912-5. PubMed ID: 877537
[TBL] [Abstract][Full Text] [Related]
9. Treatment of bronchogenic carcinoma with surgery and radiotherapy: the experience of the National Cancer Institute of Milan.
Bucalossi P; Ravasi G; Bozzetti F; Milani F
Cancer Chemother Rep 3; 1973 Mar; 4(2):101-7. PubMed ID: 4729313
[No Abstract] [Full Text] [Related]
10. Radiation plus 5-fluorouracil (NSC-19893): clinical demonstration of an additive effect in bronchogenic carcinoma.
Cohen JL; Krant MJ; Shnider BI; Matias PI; Horton J; Baxter D
Cancer Chemother Rep; 1971 Jun; 55(3):253-8. PubMed ID: 5115846
[No Abstract] [Full Text] [Related]
11. Combination chemotherapy and radiation therapy for small cell carcinoma of the lung.
Maurer LH; Tulloh M; Eagan RT; Forcier RJ; House R
Cancer Chemother Rep 3; 1973 Mar; 4(2):171-6. PubMed ID: 4354041
[No Abstract] [Full Text] [Related]
12. [Results of radiologic and cytostatic combination therapy in malignant diseases].
Hammer B
Wien Med Wochenschr; 1967 Jun; 117(25):637-41. PubMed ID: 5585442
[No Abstract] [Full Text] [Related]
13. Radiotherapy plus 5-FU compared to radiotherapy alone for inoperable and unresectable bronchogenic carcinoma.
Carr DT; Childs DS; Lee RE
Cancer; 1972 Feb; 29(2):375-80. PubMed ID: 4622422
[No Abstract] [Full Text] [Related]
14. Cytoxan therapy in the treatment of carcinoma of the lung. (Report of a five-year survival).
Castro L
W V Med J; 1974 Jun; 70(6):131-5. PubMed ID: 4524737
[No Abstract] [Full Text] [Related]
15. Results of combination treatment of lung cancer patients: surgery plus radiotherapy and surgery plus chemotherapy.
Pavlov A; Pirogov A; Trachtenberg A; Volkova M; Maximov T; Matveeva T
Cancer Chemother Rep 3; 1973 Mar; 4(2):133-5. PubMed ID: 4199644
[No Abstract] [Full Text] [Related]
16. Combined modality therapy for stage IIIMO non-oat cell bronchogenic carcinoma.
Bitran JD; Desser RK; DeMeester T; Shapiro CM; Billings A; Rubenstein L; Evans R; Colman M; Rao CY; Griem M; Golomb HM
Cancer Treat Rep; 1978 Mar; 62(3):327-32. PubMed ID: 348305
[TBL] [Abstract][Full Text] [Related]
17. Should initial treatment of small cell carcinoma include systemic chemotherapy and brain irradiation?
Hansen HH
Cancer Chemother Rep 3; 1973 Mar; 4(2):239-41. PubMed ID: 4354042
[No Abstract] [Full Text] [Related]
18. Recent therapeutic developments in lung cancer.
Hansen HH; Selawry OS
Med Ann Dist Columbia; 1971 Sep; 40(9):580-2. PubMed ID: 4939062
[No Abstract] [Full Text] [Related]
19. Combination chemotherapy of bronchogenic carcinoma with cyclophosphamide (NSC-26271) and BCNU (NSC-409962).
Curtis JE
Cancer Chemother Rep; 1974; 58(6):883-8. PubMed ID: 4614897
[No Abstract] [Full Text] [Related]
20. Combination chemotherapy and radiation therapy in small cell carcinoma of the lung.
Eagan RT; Maurer LH; Forcier RJ; Tulloh M
Cancer; 1973 Aug; 32(2):371-9. PubMed ID: 4722918
[No Abstract] [Full Text] [Related]
[Next] [New Search]
